Zhen Y - Search Results

1

Advances and challenges in the treatment of esophageal cancer.

He S, Xu J, Liu X, Zhen Y. He S, et al. Among authors: zhen y. Acta Pharm Sin B. 2021 Nov;11(11):3379-3392. doi: 10.1016/j.apsb.2021.03.008. Epub 2021 Mar 9. Acta Pharm Sin B. 2021. PMID: 34900524 Free PMC article. Review.

2

[Inhibitory effect of lidamycin on growth of colon carcinoma 26 and hepatic metastasis in mice].

Liu XJ, Dai Y, Shang Y, Li Y, Zhen YS. Liu XJ, et al. Among authors: zhen ys. Ai Zheng. 2005 Jun;24(6):641-5. Ai Zheng. 2005. PMID: 15946470 Chinese.

3

[Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].

Dai Y, Liu XJ, Zhen YS. Dai Y, et al. Among authors: zhen ys. Yao Xue Xue Bao. 2006 Jan;41(1):41-6. Yao Xue Xue Bao. 2006. PMID: 16683526 Chinese.

4

[Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway].

Lin YJ, Huang YH, Zhen YZ, Liu XJ, Zhen YS. Lin YJ, et al. Yao Xue Xue Bao. 2008 Nov;43(11):1099-105. Yao Xue Xue Bao. 2008. PMID: 19239027 Chinese.

5

Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.

Liu H, Li L, Li XQ, Liu XJ, Zhen YS. Liu H, et al. Anticancer Drugs. 2009 Jan;20(1):41-9. doi: 10.1097/CAD.0b013e328318292c. Anticancer Drugs. 2009. PMID: 19342999

6

A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice.

Zhong G, Zhang S, Li Y, Liu X, Gao R, Miao Q, Zhen Y. Zhong G, et al. Among authors: zhen y. Cancer Lett. 2010 Sep 1;295(1):124-33. doi: 10.1016/j.canlet.2010.02.020. Epub 2010 Mar 19. Cancer Lett. 2010. PMID: 20303650

7

HERG K+ channel related chemosensitivity to sparfloxacin in colon cancer cells.

Gong JH, Liu XJ, Shang BY, Chen SZ, Zhen YS. Gong JH, et al. Oncol Rep. 2010 Jun;23(6):1747-56. doi: 10.3892/or_00000820. Oncol Rep. 2010. PMID: 20428834

8

[Binding capability of lidamycin apoprotein to human breast cancer detected by tissue microarrays].

Cai L, Gao RJ, Guo XZ, Li Y, Zhen YS. Cai L, et al. Among authors: zhen ys. Yao Xue Xue Bao. 2010 May;45(5):582-8. Yao Xue Xue Bao. 2010. PMID: 20931759 Chinese.

9

[Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].

Shang BY, Shang Y, Zhen YS, Chen SZ. Shang BY, et al. Among authors: zhen ys. Yao Xue Xue Bao. 2011 Nov;46(11):1321-5. Yao Xue Xue Bao. 2011. PMID: 22260022 Chinese.

10

Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.

Gong JH, Liu XJ, Li Y, Zhen YS. Gong JH, et al. Among authors: zhen ys. Cancer Chemother Pharmacol. 2012 May;69(5):1323-32. doi: 10.1007/s00280-012-1827-9. Epub 2012 Feb 5. Cancer Chemother Pharmacol. 2012. PMID: 22311160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,494 results

Search Page

Filters